Prescription fit
Online Mounjaro care should start with the labeled use
Mounjaro is a branded tirzepatide injection with FDA-approved labeling to improve glycemic control in adults and pediatric patients age 10 and older with type 2 diabetes, used with diet and exercise. Peptide12 provides adult care. A responsible online visit should confirm why Mounjaro is being considered, whether diabetes records or glucose trends support that discussion, which current pen, vial, or KwikPen presentation is prescribed, whether Zepbound or another option is a better label fit for weight-management goals, and how follow-up will be handled before a prescription decision is made.
- A type 2 diabetes review may include A1C or glucose history, current diabetes medicines, kidney risk, weight-related goals, cardiovascular history, and prior GLP-1 or tirzepatide response.
- Mounjaro and Zepbound are separate brand products with different labels, coverage pathways, prescribing contexts, and patient-fit questions.
- Insurance approval, a coupon, or a telehealth checkout form does not replace clinician eligibility screening.